On overview of the research regarding the use of massage to improve cancer- or treatment-related symptoms and overall quality of life for patients with cancer.
According to recent research, scientists may not need to rely on the use of viral vectors to edit the genes of primary immune cells when creating cell and gene therapies.
Racial minorities are poorly represented in genomic research databases, raising important questions about whether or not all patients will benefit equally from advances in precision oncology.
An analysis of population data on cancer incidence, survival, and mortality revealed that early interventions and improvements to treatments contributed to a 26% decline in cancer deaths from 1991 to 2015.
Examining the costs and benefits of repurposing sildenafil as a cancer medication.
Results from postmarketing trials for drugs approved through FDA's accelerated approval pathway need to be produced in a more timely fashion to reveal the true benefit — or lack thereof — of the drugs approved through these expedited channels.
Multiple studies have examined the possible association between cell phone usage and increased cancer risk, but study designs, potential biases, and interpretations of statistical outcomes leave conclusions uncertain.
Q&A With Frank Luh, MD, MS, MHA and Yun Yen, MD, PhD, FACP: Looking to Broaden CMS Coverage for NGS TestsJuly 04, 2018
Restricting use to FDA-approved NGS tests is not an absolute rule that must last forever. But it's a good start, say two physicians.
There is a paucity of data regarding the long-term endocrine effects of cancer in adolescent and young adult survivors.
Exercise therapy may improve peak oxygen consumption and improve clinical outcomes, but findings from previous studies have been inconclusive.
All meta-analyses conducted to date show a significant association between indoor tanning use and an increased risk of melanoma or non-melanoma skin cancers.
Medicare Reimbursement Restrictions on Next-Generation Sequencing Could Hinder Clinical Decision-MakingJune 28, 2018
Requiring FDA approval for next-generation sequencing assays may restrict scientific development and strangle innovation.
In the short term, patients in the ICU with solid malignancies had favorable survival outcomes compared to all other ICU patients — and even in the long term, when adjusting for prognostic factors, ICU patients with cancer did not represent meaningful increases in hospital mortality risk.
Survey-based priming intervention linked to improved communication and goals-of-care discussions amongst patient-clinician pairsJune 26, 2018
Communication remains one of the cornerstone principles in the foundation of medical practice.
There are benefits and drawbacks to the public availability to DTC mutation tests.
Though mechanisms of anticancer effects of resveratrol have been identified, the ability to translate these findings to in-human studies is a challenge.
New findings bolster the case for the predictive utility of ARID1A mutations.
Data from previous studies evaluating the efficacy of atezolizumab, a PD-L1 inhibitor, have suggested that high tissue tumor mutational burden may be predictive of efficacy for checkpoint immunotherapy.
Liquid Biopsies and Cancer Detection: New Test Assesses Levels of Circulating Proteins for Early-Stage DiagnosisJune 19, 2018
A new test has been shown to be capable of identifying eight different cancers by assessing levels of circulating proteins along with mutations in cell-free DNA.
Researchers report on a retrospective cohort analysis that evaluated the long-term effects of vigorous exercise for survivors of childhood cancer.
Understanding Telomerase: Higher Quality Images Give Insight Into Developing New Agents for InhibitionJune 18, 2018
Telomerase plays a crucial role in tumor proliferation, and a better understanding of its structure will pave the way for new drug development.
Several meta-analyses suggest that coffee consumption may decrease the risk of many types of cancers, but for some cancers, the data remain mixed or indicate an increased risk.
Many studies have suggested that diabetes is a risk factor for the development of cancer, but whether or not cancer itself can increase the risk of diabetes requires further investigation.
Many clinical trials and systematic reviews note that the use of cannabinoids also comes with adverse events, including a clinical entity that has been gaining evidence in the literature over the last decade called cannabinoid hyperemesis syndrome.
Researchers hypothesized that ART, which suppresses viral load, improves immune function, and reduces inflammation, may lead to reduced cancer risk among HIV-positive patients.
Kyu Rhee, MD, MPP, discusses the latest updates at the ASCO 2018 meeting.
Charles Saunders, MD, speaks at the American Society of Clinical Oncology (ASCO) 2018 meeting in Chicago.
Josh Kremer, MD, discusses the latest research at the ASCO 2018 meeting.
Venkateshwar Reddy, MD, discusses research at the ASCO 2018 meeting.
With precision medicine nearly 23% of all patients who present with advanced lung cancer are treated with FDA- or EMA-approved targeted therapies or immunotherapies instead of chemotherapy.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Massage and Cancer
- Pembrolizumab May Lead to Favorable Long-Term Outcomes in Head and Neck Cancer
- Biomarker-Based Blood Test May Extend Reach of CT Screening for Certain Lung Cancers
- Next-Generation Sequencing Adds Value by Detecting More Mutations Than Polymerase Chain Reaction in Melanoma
- Tucatinib May Be A Safe, Novel Treatment for ERBB2/HER2-Positive Breast Cancer